Search for: "Cipla Ltd."
Results 21 - 40
of 81
Sorted by Relevance
|
Sort by Date
18 Feb 2009, 12:21 pm
The pre-grant opposition was filed by Natco Pharma Ltd. and decided by the Assistant Controller on 4th July 2007 after hearing made on 27th June 2007. [read post]
15 Apr 2009, 4:05 am
The Delhi Patent Office decided the pre-grant opposition in favor of Cipla Ltd. after it found that the applicant (Gilead) failed to provide any supportive evidence in the specification by means of comparative data or by way of examples which would have supported the inventive merit of Oseltamivir. [read post]
21 Mar 2017, 11:45 pm
Cipla Industries Pvt Ltd in India, which involved the use of a well-known mark as trade name in respect to dissimilar goods.Monday miscellanyInternKat Tian Lu recaps IP news and events including the UKIPO call for views regarding illicit IPTV streaming devices.Around the IP BlogsInternKat Tian Lu covers the latest posts from some IP blogs.UK's IP Enforcement Framework-IPO Research Bid Opportunity (Update)IPkat Neil Wilkof announces the deadline for submitting applications to… [read post]
18 Aug 2010, 12:19 am
Austworld Commodities Pty Ltd; Apotex Pty Ltd v. [read post]
21 Sep 2010, 7:47 pm
– Peanut based malnutrition treatment – humanitarian developments and compulsory licensing (IP finance) NGOs warn on IP in Trans Pacific Trade Agreement (IP Watch) Africa: African traditional knowledge and folklore given IP protection despite warning of TK commodification (IP Watch) Brazil, EU, India, Netherlands: Consultations on WTO drug transit case continue (IP Watch) EU: Vaccines causing trouble once more… Georgetown University referral to ECJ concerning SPC Regulation (The… [read post]
11 Jul 2009, 7:45 am
Post 2005, the application was separately opposed by Cancer Patients Aid Association, Natco Pharma Ltd., Cipla Ltd., Ranbaxy Ltd. and Hetero Drugs Ltd. and subsequently got rejected by the Chennai Patent Office on January 25, 2006. [read post]
15 Sep 2010, 2:40 am
KG v Apotex Pty Ltd (No 2) (Patentology) MoviPrep – US: Salix and Norgine settle with Novel in patent dispute over MoviPrep (Patent Docs) Nexavar (Sorafenib) – India: Nexavar patent infringement suit before Delhi HC goes directly to trial: Bayer v Cipla (Spicy IP) Simcor (Niacin/Simvastatin) – US: Abbott files patent infringement suit against Teva following Para IV challenge (Patent Docs) Vancocin (Vancomycin) – US: ViroPharma sues FDA over generic Vancocin;… [read post]
10 Feb 2010, 4:47 pm
Lupin Ltd. et al. [read post]
24 Jul 2008, 2:48 am
The judge gave preliminary approval last week for the company to pay $13.5 million to settle the suit.Indian Drugmaker Openly Plans for Release of Copycats: Cipla Ltd, India's second largest drug maker by sales, may launch copycat versions of 20 patented drugs of leading global drug makers, after securing similar-sounding trademarks for its copy brands.Cipla "may launch these generic brands in the market as and when the opportunity arises", claimed a company… [read post]
18 Mar 2016, 8:10 am
Cipla Ltd., 681 F.3d 1283, 1292 (Fed. [read post]
21 Jan 2010, 1:00 am
Lupin, Ltd. et al. [read post]
3 Aug 2013, 6:35 am
Serum Institute of India Ltd supplied vaccines/biologicals worth $254 million dollars, making it the largest supplier in India. [read post]
25 Nov 2009, 12:00 pm
US: Federal Circuit to hear oral argument in Ajinomoto v ITC 10 December (ITC Law Blog) US: Athena Diagnostics files suits against Ambry Genetics over alleged infringement of patents covering diagnostic technologies (Patent Docs) Products Dovonex (Calcipotriol) – UK: EWCA (Civ): Follow the instruction or lose the case - Sandoz's attempts at having finding of lack of anticipation overturned fails, appeal dismissed: Leo v Sandoz (IPKat) Famvir (Famciclovir) – US: New Jersey… [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging novelty:… [read post]
17 Feb 2010, 5:10 am
King Pharmaceuticals Inc. et al (Patent Docs) Famvir (Famciclovir) – US: Teva and Novartis settle patent litigation regarding Famciclovir (IP Factor) (SmartBrief) Gardasil, Silgard - Portugal: More on Gardasil and Silgard from Portugal (SPC Blog) Lipitor (Atorvastatin) – Philippines: UniLab can still sell generic version of Pfizer's Lipitor after a Makati court denies latter's petition for preliminary injunction (GenericsWeb) Mucinex (Guaifenesin) – US: W D Michigan rules… [read post]
17 Dec 2008, 9:57 pm
In past Patent Circle exclusively brought in notice couple of patents issued to Cipla for new forms of known drugs, namely, esomeprazole and alendronate and accused Cipla of practicing double standards on patenting so-called trivial improvements. [read post]
4 Dec 2013, 7:06 am
Cipla Ltd., 681 F.3d 1283, 1299 (Fed. [read post]
17 Apr 2009, 12:00 am
Ltd. sues 11 generics companies over Levaquin patents (Law 360) Lexapro (Escitalopram) – Netherlands District court invalidates Lundbeck’s patent EP ‘066 (IPKat) Lexapro (Escitalopram) - Baldwin’s rules explained (The SPC Blog) Lexapro (Escitalopram) – federal district Judge agrees to determine whether Forest Laboratories destroyed key documents (Law 360) Pegasys (PEG interferon alfa 2a) – Roche wins post grant opposition against… [read post]
4 Mar 2009, 11:00 pm
(Spicy IP) Kenya enacts Biosafety Act 2/2009 regulating activities in GMOs, establishing National Biosafety Authority (Afro-IP) US: BIO meets the press: economic health of the biotech industry; follow-on biologics; patent reform (Patent Docs) (Patent Docs) (Intellectual Property Watch) US: Obama touts generic biologics to lower drug costs (Law360) US: Genentech announces victory in Cabilly re-examination (Patent Docs) US: Federal judge rejects Scruggs family’s bid to reconsider summary… [read post]
25 Aug 2010, 12:37 am
Torrent Pharmaceuticals Ltd. et al. [read post]
